Levoxyl (levothyroxine sodium) tablets, USP, 100 mcg, packaged in a) 100-count bottles (NDC 60793-854-01) and b) 1000-count bottles (NDC 60793-854-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
Check against the official notice below — it lists the full affected range.
King Legacy, a Pfizer subsidiary, is recalling Levoxyl (levothyroxine sodium) tablets, 100 mcg, distributed nationwide and in Puerto Rico. The recall affects approximately 195,201 bottles in two package sizes: 100-count bottles and 1000-count bottles. The products are being recalled because they were found to be subpotent, meaning they contained less active ingredient than specified at their expiration dates.
The recalled products include multiple lot numbers with expiration dates ranging from April 2013 through November 2013 for the 100-count bottles and April 2013 through August 2013 for the 1000-count bottles. The source document does not specify what action affected consumers should take regarding this recall.
Written by software from the official notice below. Not reviewed by a lawyer.
Subpotent Drug: The products were below specification for potency at the expiry stability point.
Reason for recall: Subpotent Drug: The products were below specification for potency at the expiry stability point. Distribution: Nationwide and Puerto Rico Quantity: 195,201 bottles Lot/code info: Lot # a) 64341, Exp 04/13; 64928, Exp. 5/13; 65064, Exp. 5/13; 65233, Exp. 7/13; 66162, Exp. 8/13; 66365, Exp. 10/13; and 66677, Exp. 11/13; b) 64342, Exp. 4/13; 64929, Exp. 5/13; 65065, Exp. 5/13; 65234, Exp. 7/13; 65539, Exp. 7/13; 65901, Exp. 8/13; and 66163, Exp. 8/13
Official record: FDA (Drug enforcement) ↗
Republished from the official source above; details can change — the source record controls.